Helicobacter Pylori Infection
📧 Sign up to get email alerts when something new happens for Helicobacter Pylori Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-03-11FDA Approved: BERKLEY AND JENSEN OMEPRAZOLE — Supplemental Application (BJWC)
The FDA approved a supplemental application for Berkley and Jensen Omeprazole (omeprazole) submitted by BJWC.
-
FDA approval · 2026-03-11FDA Approved: EQUATE LANSOPRAZOLE — Supplemental Application (Wal-Mart Stores Inc)
FDA approved a supplemental application for Equate Lansoprazole (lansoprazole) by Wal-Mart Stores Inc, enabling the store-brand generic prot…
-
EMA approval · 2026-02-06EMA Authorised: Helicobacter Test INFAI (urea (13C)) — INFAI, Institut für biomedizinische Analytik NMR-Imaging GmbH
The EMA authorised the Helicobacter Test INFAI (urea-13C), a breath test for detecting Helicobacter pylori infection, developed by INFAI, In…
-
FDA approval · 2025-12-10FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Original Application (ANI Pharmaceuticals, Inc.)
FDA approved ANI Pharmaceuticals' original application for a generic omeprazole and sodium bicarbonate combination product.
-
FDA approval · 2025-11-21FDA Approved: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE — Supplemental Application (H2-Pharma, LLC)
FDA approved a supplemental application for the combination therapy Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochlori…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-11-06FDA Approved: VOQUEZNA — Supplemental Application (Phathom Pharmaceuticals Inc.)
The FDA approved a supplemental application for Voquezna (vonoprazan fumarate) from Phathom Pharmaceuticals, expanding its labeling for Heli…
-
FDA approval · 2025-10-31FDA Approved: VOQUEZNA DUAL PAK — Supplemental Application (Phathom Pharmaceuticals Inc.)
The FDA approved a supplemental application for Voquezna Dual Pak, a combination of vonoprazan and amoxicillin from Phathom Pharmaceuticals,…
-
FDA approval · 2025-10-31FDA Approved: VOQUEZNA TRIPLE PAK — Supplemental Application (Phathom Pharmaceuticals Inc.)
The FDA approved a supplemental application for Voquezna Triple Pak, a three-drug regimen of vonoprazan fumarate, amoxicillin, and clarithro…
-
FDA approval · 2025-06-12FDA Approved: VOQUEZNA TRIPLE PAK — Supplemental Application (Phathom Pharmaceuticals Inc.)
The FDA approved a supplemental application for Voquezna Triple Pak, a three-drug regimen (vonoprazan fumarate, amoxicillin, and clarithromy…
-
FDA approval · 2025-06-12FDA Approved: VOQUEZNA DUAL PAK — Supplemental Application (Phathom Pharmaceuticals Inc.)
FDA approved a supplemental application for Voquezna Dual Pak (vonoprazan fumarate and amoxicillin) from Phathom Pharmaceuticals. The approv…
-
FDA approval · 2025-03-31FDA Approved: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE — Supplemental Application (H2-Pharma, LLC)
The FDA approved a supplemental application for the fixed-dose combination of bismuth subcitrate potassium, metronidazole, and tetracycline …
-
FDA approval · 2025-03-06FDA Approved: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE — Supplemental Application (Endo USA, Inc.)
The FDA approved a supplemental application for Endo USA, Inc.'s generic fixed-dose combination of bismuth subcitrate potassium, metronidazo…
-
FDA approval · 2025-03-05FDA Approved: ESOMEPRAZOLE MAGNESIUM FOR DELAYED-RELEASE ORAL SUSPENSION — Original Application (Torrent Pharmaceuticals Limited)
FDA approved Torrent Pharmaceuticals' esomeprazole magnesium delayed-release oral suspension via an original application, providing a generi…
-
FDA approval · 2024-12-19FDA Approved: LANSOPRAZOLE — Supplemental Application (Medcore LLC)
The FDA approved a supplemental application for lansoprazole from Medcore LLC, enabling a generic lansoprazole product to be marketed under …
-
FDA approval · 2024-12-19FDA Approved: LANSOPRAZOLE — Supplemental Application (NorthStar Rx LLC)
The FDA approved a supplemental application for lansoprazole submitted by NorthStar Rx LLC.
-
FDA approval · 2024-12-10FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for esomeprazole magnesium from Ascend Laboratories, LLC, under an approved ANDA.
-
FDA approval · 2024-11-27FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for pantoprazole sodium from Amneal Pharmaceuticals LLC, updating the approval for this generic prot…
-
FDA approval · 2024-11-12FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for esomeprazole magnesium from Mylan Pharmaceuticals, enabling the generic product to be marketed w…
-
FDA approval · 2024-11-05FDA Approved: RABEPRAZOLE SODIUM — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for rabeprazole sodium (Amneal Pharmaceuticals LLC).
-
FDA approval · 2024-11-04FDA Approved: LANSOPRAZOLE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved a generic version of lansoprazole via an Original Abbreviated New Drug Application for Macleods Pharmaceuticals Limited.
-
FDA approval · 2024-10-23FDA Approved: ESOMEPRAZOLE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Esomeprazole under an Original Application for Macleods' generic product, enabling generic market access.
-
FDA approval · 2024-09-19FDA Approved: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE — Supplemental Application (H2-Pharma, LLC)
FDA approved a supplemental application for the combination drug Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride.…
-
FDA approval · 2024-07-31FDA Approved: VOQUEZNA TRIPLE PAK — Supplemental Application (Phathom Pharmaceuticals Inc.)
The FDA approved a supplemental application for Voquezna Triple Pak (vonoprazan fumarate, amoxicillin and clarithromycin) from Phathom Pharm…
-
FDA approval · 2024-07-31FDA Approved: VOQUEZNA DUAL PAK — Supplemental Application (Phathom Pharmaceuticals Inc.)
FDA approved a supplemental application for Voquezna Dual Pak, a combination of vonoprazan fumarate and amoxicillin, to treat Helicobacter p…
-
FDA approval · 2024-07-17FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Somerset Therapeutics, LLC)
FDA approved a supplemental application for esomeprazole magnesium by Somerset Therapeutics, LLC.